VEGFA and diabetic macular edema: This observational analysis evaluated whether serum 25-hydroxyvitamin D [25(OH)D] concentrations correlate with short-term treatment response to intravitreal anti–vascular endothelial growth factor (anti-VEGF) therapy in individuals diagnosed with diabetic macular edema (DME).